Extending Adjuvant Endocrine Therapy in Breast Cancer: Who, What, Why?

In this article, we provide a case-based expert opinion on the duration of extended adjuvant endocrine therapy, use of biomarkers in guiding this decision, and toxicities to be considered when recommending this treatment.

Source: CancerNetwork - June 19, 2019 Category: Cancer & Oncology Authors: Shaveta Vinayak, MD, MS, Nancy E. Davidson, MD Source Type: news